Supplementary Fig. S5 from Emergence of Enzalutamide Resistance in Prostate Cancer is Associated with BCL-2 and IKKB Dependencies

Abstract

Treatment of BCL-2 and IKKB inhibitor decreases cell growth and induces cell death in ENZ-resistant cell lines